Consensus Declaration of EQUAM 6 July 2002 by The European Committee on Quality Assurance and Medical Devicesin Plastic Surgery, -
On 6 July 2002, EQUAM issued its Vth Consensus Dec-
laration, which reads as follows: 
EQUAM, the European Committee on Quality Assuran-
ce and Medical Devices in Plastic Surgery, is dedicated to
the assurance of the safe use of medical devices, techno-
logies and procedures in plastic surgery, and to the gu-
arantee of patients' safety. After review and evaluation of
current literature and scientific data, EQUAM raises con-
cerns regarding the potentially deleterious use of pro-
ducts, devices and technology, or their application for
unintended or unsuitable indications.
Breast Implants
1 .  S o y b e a n  O i l - f i l l e d  B r e a s t  I m p l a n t s
( Tr i l u c e n t  T M)
A. Recent laboratory findings and evaluation of availa-
ble data, indicate the presence of potentially hazar-
dous components in the breakdown products of soybe-
an oil filler.
B. EQUAM, therefore, emphasizes the need for imme-
diate explantation of these implants.
2 .  S i l i c o n e  G e l - f i l l e d  B r e a s t  I m p l a n t s
A. Since EQUAM's former declarations, silicone conti-
nues to be widely used. No better alternative material
has become available.
B. Additional medical studies have not demonstrated any
association between silicone-gel filled breast implants
and traditional auto-immune or connective tissue dise-
ases, cancer or any other malignant disease. These stu-
dies re-affirm prior data.
C. Silicone-gel filled breast implants do not adversely af-
fect pregnancy, fetal development, breast feeding or
the health of breast-fed children.
D. EQUAM believes it is important to advise patients of
the hazards and risks as well as the benefits of breast
augmentation or reconstructive surgery and has prepa-
red a Patients Information and Consent Form to be
used in discussion with the patient. A reasonable pe-
riod of time should be allowed between consultation
and surgery. It is recommended to postpone the in-
sertion of implants until after the age of eighteen years,
unless medically indicated.
E. Patients with breast implants should have regular fol-
low-up.
F. No routine replacement of implants is mandatory.
G. EQUAM calls for continuous clinical and scientifc re-
search for documentation and monitoring of breast
implants.
3 .  N a t i o n a l  a n d  I n t e r n a t i o n a l  B r e a s t
I m p l a n t  Re g i s t r i e s
EQUAM believes that national and international
registries of breast implants are crucial to obtain informa-
tion on short- and long-term complications and risks, and
for post-implantation surveillance. Principles of confden-
tiality and the safeguarding of the privacy of both pa-
tients and surgeons must be maintained for such a registry
to be successful. EQUAM upholds the necessity for natio-
nal breast implant registries, which may serve as a founda-
tion for the International Breast Implant Registry (IBIR),
applying a universal form.
The IBIR will serve to reassure patients, surgeons,
health authorities and the general public of the commit-
ment to safety on the part of the plastic surgery communi-
ty in the implementationof medical devices and technolo-
gies used in plastic surgery.
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Przedstawiam fragment najnowszego dokumentu European Com-
mittee on Quality Assurance and Medical Devices in Plastic Surge-
ry. Mo˝e on byç przedmiotem zainteresowania Êrodowiska onkolo-
gicznego, dotyczy bowiem wszczepów piersiowych (endoprotez),
u˝ywanych m.in. do rekonstrukcji.
Edward Towpik - delegat Polski w EQUAM
